Testing for HCV infection: an update of guidance for clinicians and laboratorians

    Insights

    An estimated 3.2 million people in the US live with hepatitis C virus (HCV) infection. New cases are linked to drug injection and healthcare exposures, highlighting ongoing public health challenges.

    Area of Science:

    • Public Health
    • Epidemiology
    • Infectious Diseases

    Background:

    • Hepatitis C virus (HCV) infection remains a significant public health concern in the United States.
    • Understanding the current prevalence and transmission routes is crucial for effective control strategies.

    Purpose of the Study:

    • To estimate the current number of persons living with hepatitis C virus infection in the US.
    • To identify key populations and settings associated with new HCV infections.

    Main Methods:

    • The study likely utilized epidemiological data and statistical modeling to estimate HCV prevalence.
    • Analysis focused on identifying demographic and exposure-related factors for new infections.

    Main Results:

    • An estimated 4.1 million individuals have been infected with HCV in the US.
    • Approximately 3.2 million people are currently living with chronic HCV infection.
    • New infections are predominantly reported among people who inject drugs and those with healthcare exposures.

    Conclusions:

    • HCV infection continues to affect a substantial portion of the US population.
    • Targeted interventions are needed for high-risk groups, including people who inject drugs.
    • Improving infection control in healthcare settings is essential to prevent further transmission.

    Related Concept Videos

    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
    Standard Precaution01:26

    Standard Precaution

    Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
    Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...